G639-2366 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-1-[5-(pyridin-3-yl)-1H-pyrazole-3-carbonyl]piperidine-3-carboxamide

G639-2366 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-1-[5-(pyridin-3-yl)-1H-pyrazole-3-carbonyl]piperidine-3-carboxamide
G639-2366 Screening compound: N-[2-(cyclohex-1-en-1-yl)ethyl]-1-[5-(pyridin-3-yl)-1H-pyrazole-3-carbonyl]piperidine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G639-2366
N-[2-(cyclohex-1-en-1-yl)ethyl]-1-[5-(pyridin-3-yl)-1H-pyrazole-3-carbonyl]piperidine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G639-2366

Molecular Formula

C23H29N5O2 (C23 H29 N5 O2)

Compound Name

N-[2-(cyclohex-1-en-1-yl)ethyl]-1-[5-(pyridin-3-yl)-1H-pyrazole-3-carbonyl]piperidine-3-carboxamide

IUPAC name

N-[2-(cyclohex-1-en-1-yl)ethyl]-1-[5-(pyridin-3-yl)-1H-pyrazole-3-carbonyl]piperidine-3-carboxamide

SMILES

O=C(C(CCC1)CN1C(c1n[nH]c(-c2cnccc2)c1)=O)NCCC1=CCCCC1

InChI

InChI=1S/C23H29N5O2/c29-22(25-12-10-17-6-2-1-3-7-17)19-9-5-13-28(16-19)23(30)21-14-20(26-27-21)18-8-4-11-24-15-18/h4,6,8,11,14-15,19H,1-3,5,7,9-10,12-13,16H2,(H,25,29)(H,26,27)/t19-/m0/s1

InChI Key

WCXLMLFVVTYNMU-IBGZPJMESA-N

MDL Number (MFCD)

MFCD27147701

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

407.52

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.211

Distribution Coefficient, logD

2.211

Water Solubility, LogSw

-2.35

Polar Surface Area

73.275

Acid Dissociation Constant (pKa)

11.62

Base Dissociation Constant (pKb)

3.73

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.80

G639-2366 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G639-2366 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G639-2366?
Check Price and Availability of G639-2366, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G639-2366 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G639-2366
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G639-2366
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G639-2366 available by request